High DRP1 expression is associated with poor survival in patients with osteosarcoma but predicts better outcomes in patients with rhabdomyosarcoma, suggesting that mitochondrial fission plays a tumor type–dependent role in the therapeutic response. Here, DNM1L is linked to rhabdomyosarcoma.